Rabies is one of the most deadly infectious diseases, with a case-fatality rate approaching
100%. The disease is established on all continents apart from Antarctica; most cases are …

Rabies is a zoonotic, fatal and progressive neurological infection caused by rabies virus of
the genus Lyssavirus and family Rhabdoviridae. It affects all warm-blooded animals and the …

In a randomized clinical trial of 86 hospitalized COVID-19 patients comparing standard care
to treatment with 300mL convalescent plasma containing high titers of neutralizing SARS …

While active immunization elicits a lasting immune response by the body, passive
immunotherapy transiently equips the body with exogenously generated immunological …

A new tentative lyssavirus, Lleida bat lyssavirus, was found in a bent-winged bat
(Miniopterus schreibersii) in Spain. It does not belong to phylogroups I or II, and it seems to …

The emergence of extremely resistant and panresistant Gram-negative bacilli, such as
Acinetobacter baumannii, requires consideration of nonantimicrobial therapeutic …

Background: Biomedical research has recently moved through three stages in digital
healthcare:(1) data collection;(2) data sharing; and (3) data analytics. With the explosion of …

Neutralizing antibodies play an essential part in antiviral immunity and are instrumental in
preventing or modulating viral diseases. Polyclonal antibody preparations are increasingly …

Rabies is a fatal encephalitis caused by rabies virus (RABV), and no antiviral drugs for
RABV are currently available. We report for the first time the efficacy of favipiravir (T-705) …

Infections with rabies virus (RABV) and related lyssaviruses are uniformly fatal once virus
accesses the central nervous system (CNS) and causes disease signs. Current …